of FR940405-1-00039 29 386 419 434 486 499 549 558 565 601 628 637 681 724 734 826 973 976 1005 1160 1162 1175 1178 1203 1230 1279 1285 1298 1318 1342
social FR940405-1-00039 1 387
support FR940405-1-00039 1 388
[ FR940405-1-00039 9 389 445 639 649 828 986 995 1166 1210
ex FR940405-1-00039 9 390 446 640 650 829 987 996 1167 1211
. FR940405-1-00039 48 391 394 416 447 450 478 508 533 543 583 607 611 641 644 648 651 690 706 727 739 772 802 811 830 833 866 900 929 988 991 997 1017 1043 1065 1088 1111 1123 1133 1152 1164 1168 1186 1205 1212 1226 1276 1334 1366
4200 FR940405-1-00039 1 392
] FR940405-1-00039 9 393 449 643 653 832 990 999 1170 1214
indoor FR940405-1-00039 5 395 422 441 495 1009
air FR940405-1-00039 8 396 423 517 521 529 1010 1032 1125
pollution FR940405-1-00039 3 397 424 1011
may FR940405-1-00039 8 398 718 737 753 780 787 805 818
be FR940405-1-00039 8 399 589 714 754 788 791 820 1130
caused FR940405-1-00039 1 400
by FR940405-1-00039 4 401 413 421 1222
physical FR940405-1-00039 1 402
, FR940405-1-00039 56 403 405 409 460 466 473 475 501 503 518 525 536 596 632 654 662 673 695 716 729 752 766 775 779 798 854 856 878 880 893 896 909 911 915 921 925 947 949 963 1026 1035 1052 1056 1071 1073 1101 1104 1107 1239 1249 1260 1301 1303 1355 1358 1361
chemical FR940405-1-00039 4 404 843 922 1046
or FR940405-1-00039 7 406 476 799 808 881 897 1256
microbiological FR940405-1-00039 1 407
agents FR940405-1-00039 1 408
and FR940405-1-00039 38 410 456 467 504 526 574 594 597 603 674 685 696 746 851 857 860 864 889 912 923 971 978 993 1037 1053 1057 1074 1081 1105 1120 1235 1261 1287 1304 1326 1329 1351 1362
is FR940405-1-00039 5 411 586 934 1154 1188
aggravated FR940405-1-00039 1 412
poor FR940405-1-00039 1 414
ventilation FR940405-1-00039 2 415 1033
the FR940405-1-00039 37 417 479 494 537 544 550 568 575 580 618 635 658 676 682 691 698 701 704 759 793 838 901 918 969 1013 1143 1158 1181 1196 1199 1247 1265 1277 1299 1335 1340 1343
causation FR940405-1-00039 1 418
sbs FR940405-1-00039 6 420 638 817 1163 1179 1273
was FR940405-1-00039 4 425 541 693 1217
first FR940405-1-00039 1 426
objectively FR940405-1-00039 2 427 634
demonstrated FR940405-1-00039 2 428 712
in FR940405-1-00039 19 429 431 493 522 530 615 655 792 876 904 950 957 980 1012 1061 1149 1180 1218 1324
1984 FR940405-1-00039 1 430
a FR940405-1-00039 16 432 484 556 562 599 721 824 935 938 944 1003 1173 1219 1223 1228 1283
study FR940405-1-00039 1 433
62 FR940405-1-00039 2 435 660
danish FR940405-1-00039 3 436 523 531
subjects FR940405-1-00039 7 437 452 480 661 665 677 699
suffering FR940405-1-00039 2 438 768
from FR940405-1-00039 9 439 471 769 1022 1030 1040 1084 1145 1198
`` FR940405-1-00039 2 440 514
climate FR940405-1-00039 1 442
symptoms FR940405-1-00039 8 443 748 782 839 868 899 903 1281
'' FR940405-1-00039 2 444 516
420 FR940405-1-00039 2 448 642
these FR940405-1-00039 6 451 509 625 708 1018 1192
reported FR940405-1-00039 7 453 587 1115 1215 1243 1263 1338
primarily FR940405-1-00039 1 454
eye FR940405-1-00039 2 455 908
upper FR940405-1-00039 2 457 1350
respiratory FR940405-1-00039 3 458 1289 1353
irritation FR940405-1-00039 4 459 680 914 1354
but FR940405-1-00039 2 461 823
were FR940405-1-00039 4 462 481 1242 1251
otherwise FR940405-1-00039 1 463
healthy FR940405-1-00039 1 464
individuals FR940405-1-00039 4 465 741 774 979
did FR940405-1-00039 2 468 670
not FR940405-1-00039 4 469 671 686 819
suffer FR940405-1-00039 1 470
asthma FR940405-1-00039 2 472 1360
allergy FR940405-1-00039 2 474 1027
bronchitis FR940405-1-00039 1 477
exposed FR940405-1-00039 2 482 666
to FR940405-1-00039 32 483 513 554 578 588 591 605 624 679 687 713 756 790 871 927 952 959 982 1008 1028 1048 1077 1086 1093 1117 1129 1142 1190 1233 1244 1253 1264
mixture FR940405-1-00039 1 485
22 FR940405-1-00039 1 487
volatile FR940405-1-00039 2 488 629
organic FR940405-1-00039 2 489 630
chemicals FR940405-1-00039 3 490 631 1051
commonly FR940405-1-00039 1 491
found FR940405-1-00039 3 492 612 663
environment FR940405-1-00039 2 496 762
at FR940405-1-00039 3 497 800 1258
concentrations FR940405-1-00039 2 498 510
0 FR940405-1-00039 1 500
5 FR940405-1-00039 1 502
25 FR940405-1-00039 1 505
mg/m FR940405-1-00039 1 506
3 FR940405-1-00039 1 507
corresponded FR940405-1-00039 1 511
respectively FR940405-1-00039 1 512
clean FR940405-1-00039 1 515
average FR940405-1-00039 1 519
polluted FR940405-1-00039 2 520 528
houses FR940405-1-00039 2 524 532
maximum FR940405-1-00039 1 527
after FR940405-1-00039 1 534
exposure FR940405-1-00039 7 535 623 692 705 844 1079 1085
digit FR940405-1-00039 3 538 545 619
span FR940405-1-00039 3 539 546 620
test FR940405-1-00039 4 540 547 585 621
administered FR940405-1-00039 1 542
consists FR940405-1-00039 1 548
subject FR940405-1-00039 2 551 576
being FR940405-1-00039 1 552
allowed FR940405-1-00039 1 553
view FR940405-1-00039 2 555 1204
series FR940405-1-00039 1 557
random FR940405-1-00039 1 559
digits FR940405-1-00039 1 560
for FR940405-1-00039 7 561 667 763 795 937 968 1193
short FR940405-1-00039 1 563
period FR940405-1-00039 1 564
time FR940405-1-00039 1 566
; FR940405-1-00039 19 567 847 849 859 884 888 1080 1291 1293 1296 1306 1308 1310 1312 1314 1316 1320 1322 1328
numbers FR940405-1-00039 1 569
are FR940405-1-00039 4 570 731 907 1140
then FR940405-1-00039 1 571
covered FR940405-1-00039 1 572
up FR940405-1-00039 1 573
asked FR940405-1-00039 1 577
repeat FR940405-1-00039 1 579
sequence FR940405-1-00039 1 581
backwards FR940405-1-00039 1 582
this FR940405-1-00039 2 584 834
sensitive FR940405-1-00039 3 590 1015 1141
situational FR940405-1-00039 1 592
anxiety FR940405-1-00039 1 593
alertness FR940405-1-00039 1 595
therefore FR940405-1-00039 1 598
measure FR940405-1-00039 1 600
stress FR940405-1-00039 2 602 771
ability FR940405-1-00039 1 604
concentrate FR940405-1-00039 1 606
bach FR940405-1-00039 1 608
et FR940405-1-00039 2 609 646
al FR940405-1-00039 2 610 647
significant FR940405-1-00039 1 613
declines FR940405-1-00039 1 614
performance FR940405-1-00039 1 616
on FR940405-1-00039 4 617 657 1157 1216
following FR940405-1-00039 1 622
low FR940405-1-00039 1 626
levels FR940405-1-00039 1 627
demonstrating FR940405-1-00039 1 633
existence FR940405-1-00039 1 636
molhave FR940405-1-00039 1 645
4228 FR940405-1-00039 1 652
reporting FR940405-1-00039 1 656
same FR940405-1-00039 1 659
that FR940405-1-00039 10 664 675 785 816 837 932 1137 1208 1270 1339
23/4 FR940405-1-00039 1 668
hrs FR940405-1-00039 1 669
adapt FR940405-1-00039 1 672
reacted FR940405-1-00039 1 678
mucous FR940405-1-00039 1 683
membranes FR940405-1-00039 1 684
odor FR940405-1-00039 1 688
intensity FR940405-1-00039 1 689
doubledblind FR940405-1-00039 1 694
neither FR940405-1-00039 1 697
nor FR940405-1-00039 1 700
testers FR940405-1-00039 1 702
knew FR940405-1-00039 1 703
although FR940405-1-00039 2 707 767
problems FR940405-1-00039 8 709 735 1006 1019 1197 1231 1275 1290
have FR940405-1-00039 4 710 1000 1114 1245
been FR940405-1-00039 2 711 814
real FR940405-1-00039 1 715
they FR940405-1-00039 4 717 786 1271 1347
affect FR940405-1-00039 1 719
only FR940405-1-00039 1 720
small FR940405-1-00039 1 722
percentage FR940405-1-00039 1 723
building FR940405-1-00039 4 725 761 794 1220
occupants FR940405-1-00039 1 726
also FR940405-1-00039 4 728 965 1067 1135
there FR940405-1-00039 3 730 933 1153
various FR940405-1-00039 1 732
degrees FR940405-1-00039 1 733
which FR940405-1-00039 2 736 948
occur FR940405-1-00039 1 738
some FR940405-1-00039 2 740 1138
who FR940405-1-00039 1 742
experience FR940405-1-00039 1 743
relatively FR940405-1-00039 1 744
mild FR940405-1-00039 1 745
treatable FR940405-1-00039 1 747
such FR940405-1-00039 2 749 1097
as FR940405-1-00039 5 750 941 943 1098 1227
headache FR940405-1-00039 3 751 848 1292
able FR940405-1-00039 1 755
cope FR940405-1-00039 1 757
with FR940405-1-00039 3 758 842 1331
sick FR940405-1-00039 1 760
extended FR940405-1-00039 2 764 796
periods FR940405-1-00039 2 765 797
increased FR940405-1-00039 1 770
other FR940405-1-00039 4 773 1112 1121 1236
more FR940405-1-00039 1 776
seriously FR940405-1-00039 1 777
affected FR940405-1-00039 1 778
find FR940405-1-00039 1 781
so FR940405-1-00039 1 783
severe FR940405-1-00039 1 784
unable FR940405-1-00039 1 789
all FR940405-1-00039 1 801
still FR940405-1-00039 1 803
others FR940405-1-00039 1 804
become FR940405-1-00039 1 806
temporarily FR940405-1-00039 1 807
permanently FR940405-1-00039 1 809
disabled FR940405-1-00039 1 810
it FR940405-1-00039 2 812 1187
has FR940405-1-00039 2 813 1171
suggested FR940405-1-00039 1 815
one FR940405-1-00039 2 821 1206
syndrome FR940405-1-00039 2 822 1357
number FR940405-1-00039 2 825 1004
subs FR940405-1-00039 2 827 920
4170 FR940405-1-00039 1 831
hypothesis FR940405-1-00039 1 835
suggests FR940405-1-00039 1 836
particularly FR940405-1-00039 2 840 1131
associated FR940405-1-00039 1 841
include FR940405-1-00039 4 845 862 891 1020
fatigue FR940405-1-00039 3 846 1075 1309
dry FR940405-1-00039 2 850 1049
irritated FR940405-1-00039 1 852
eyes FR940405-1-00039 3 853 887 1300
nose FR940405-1-00039 3 855 883 910
throat FR940405-1-00039 3 858 913 1295
sometimes FR940405-1-00039 2 861 890
nausea FR940405-1-00039 2 863 1321
dizziness FR940405-1-00039 1 865
those FR940405-1-00039 1 867
most FR940405-1-00039 1 869
related FR940405-1-00039 3 870 1232 1274
microbial FR940405-1-00039 2 872 924
exposures FR940405-1-00039 1 873
would FR940405-1-00039 2 874 964
result FR940405-1-00039 2 875 1229
itchy FR940405-1-00039 2 877 885
congested FR940405-1-00039 1 879
runny FR940405-1-00039 1 882
watery FR940405-1-00039 1 886
wheezing FR940405-1-00039 1 892
tight FR940405-1-00039 1 894
chest FR940405-1-00039 1 895
flulike FR940405-1-00039 1 898
overlapping FR940405-1-00039 1 902
each FR940405-1-00039 1 905
case FR940405-1-00039 1 906
perhaps FR940405-1-00039 1 916
making FR940405-1-00039 1 917
two FR940405-1-00039 1 919
difficult FR940405-1-00039 1 926
distinguish FR940405-1-00039 1 928
jones FR940405-1-00039 1 930
concludes FR940405-1-00039 1 931
need FR940405-1-00039 1 936
treatment FR940405-1-00039 2 939 984
protocol FR940405-1-00039 2 940 946
well FR940405-1-00039 1 942
diagnostic FR940405-1-00039 2 945 961
addition FR940405-1-00039 1 951
describing FR940405-1-00039 1 953
corrective FR940405-1-00039 1 954
actions FR940405-1-00039 1 955
available FR940405-1-00039 1 956
response FR940405-1-00039 1 958
different FR940405-1-00039 1 960
findings FR940405-1-00039 1 962
provide FR940405-1-00039 1 966
guidelines FR940405-1-00039 1 967
design FR940405-1-00039 1 970
implementation FR940405-1-00039 1 972
followup FR940405-1-00039 1 974
studies FR940405-1-00039 1 975
buildings FR940405-1-00039 1 977
order FR940405-1-00039 1 981
assess FR940405-1-00039 1 983
effectiveness FR940405-1-00039 1 985
3170 FR940405-1-00039 1 989
randolph FR940405-1-00039 3 992 1044 1089
moss FR940405-1-00039 1 994
4258 FR940405-1-00039 1 998
written FR940405-1-00039 1 1001
about FR940405-1-00039 1 1002
ascribed FR940405-1-00039 1 1007
chemically FR940405-1-00039 1 1014
patient FR940405-1-00039 2 1016 1336
irritability FR940405-1-00039 1 1021
natural FR940405-1-00039 1 1023
gas FR940405-1-00039 1 1024
fumes FR940405-1-00039 2 1025 1042
dust FR940405-1-00039 1 1029
forced FR940405-1-00039 1 1031
systems FR940405-1-00039 1 1034
intoxication FR940405-1-00039 1 1036
even FR940405-1-00039 1 1038
hallucination FR940405-1-00039 1 1039
paint FR940405-1-00039 1 1041
describes FR940405-1-00039 4 1045 1068 1091 1136
sensitivity FR940405-1-00039 1 1047
cleaning FR940405-1-00039 1 1050
rug FR940405-1-00039 1 1054
shampoo FR940405-1-00039 1 1055
implicates FR940405-1-00039 1 1058
moldy FR940405-1-00039 1 1059
carpets FR940405-1-00039 1 1060
producing FR940405-1-00039 1 1062
allergenic FR940405-1-00039 1 1063
substances FR940405-1-00039 1 1064
he FR940405-1-00039 2 1066 1134
joint FR940405-1-00039 1 1069
pain FR940405-1-00039 1 1070
malaise FR940405-1-00039 1 1072
due FR940405-1-00039 1 1076
pesticide FR940405-1-00039 1 1078
skin FR940405-1-00039 2 1082 1305
rashes FR940405-1-00039 2 1083 1307
plasticizers FR940405-1-00039 1 1087
further FR940405-1-00039 1 1090
intolerance FR940405-1-00039 1 1092
highly FR940405-1-00039 1 1094
scented FR940405-1-00039 1 1095
products FR940405-1-00039 1 1096
deodorant FR940405-1-00039 1 1099
soaps FR940405-1-00039 1 1100
toilet FR940405-1-00039 1 1102
deodorants FR940405-1-00039 1 1103
disinfectants FR940405-1-00039 1 1106
especially FR940405-1-00039 1 1108
pinescented FR940405-1-00039 1 1109
ones FR940405-1-00039 1 1110
patients FR940405-1-00039 2 1113 1139
reacting FR940405-1-00039 1 1116
strong FR940405-1-00039 1 1118
perfumes FR940405-1-00039 1 1119
cosmetics FR940405-1-00039 1 1122
socalled FR940405-1-00039 1 1124
fresheners FR940405-1-00039 1 1126
often FR940405-1-00039 1 1127
prove FR940405-1-00039 1 1128
troublesome FR940405-1-00039 1 1132
odors FR940405-1-00039 1 1144
hot FR940405-1-00039 1 1146
plasticcoated FR940405-1-00039 1 1147
wires FR940405-1-00039 1 1148
electronic FR940405-1-00039 1 1150
equipment FR940405-1-00039 1 1151
little FR940405-1-00039 1 1155
data FR940405-1-00039 1 1156
perceptions FR940405-1-00039 1 1159
victims FR940405-1-00039 3 1161 1182 1200
shapiro FR940405-1-00039 2 1165 1209
4282 FR940405-1-00039 2 1169 1213
complied FR940405-1-00039 1 1172
summary FR940405-1-00039 1 1174
16 FR940405-1-00039 1 1176
casehistories FR940405-1-00039 1 1177
' FR940405-1-00039 2 1183 1201
own FR940405-1-00039 1 1184
words FR940405-1-00039 1 1185
useful FR940405-1-00039 1 1189
review FR940405-1-00039 1 1191
insight FR940405-1-00039 1 1194
into FR940405-1-00039 1 1195
point FR940405-1-00039 1 1202
episode FR940405-1-00039 1 1207
occupied FR940405-1-00039 1 1221
government FR940405-1-00039 1 1224
agency FR940405-1-00039 3 1225 1248 1266
carpeting FR940405-1-00039 1 1234
suspected FR940405-1-00039 1 1237
causes FR940405-1-00039 1 1238
five FR940405-1-00039 1 1240
workers FR940405-1-00039 1 1241
left FR940405-1-00039 1 1246
11 FR940405-1-00039 1 1250
relocated FR940405-1-00039 1 1252
alternative FR940405-1-00039 1 1254
workspace FR940405-1-00039 1 1255
worked FR940405-1-00039 1 1257
home FR940405-1-00039 1 1259
100 FR940405-1-00039 1 1262
's FR940405-1-00039 2 1267 1337
medical FR940405-1-00039 1 1268
officer FR940405-1-00039 1 1269
had FR940405-1-00039 1 1272
range FR940405-1-00039 1 1278
selfreported FR940405-1-00039 1 1280
included FR940405-1-00039 2 1282 1349
variety FR940405-1-00039 1 1284
moderate FR940405-1-00039 1 1286
acute FR940405-1-00039 1 1288
sore FR940405-1-00039 1 1294
burning FR940405-1-00039 1 1297
lungs FR940405-1-00039 1 1302
laryngitis FR940405-1-00039 1 1311
clumsiness FR940405-1-00039 1 1313
disorientation FR940405-1-00039 1 1315
loss FR940405-1-00039 1 1317
balance FR940405-1-00039 1 1319
numbness FR940405-1-00039 1 1323
extremities FR940405-1-00039 1 1325
face FR940405-1-00039 1 1327
difficulty FR940405-1-00039 1 1330
mental FR940405-1-00039 1 1332
tasks FR940405-1-00039 1 1333
diagnoses FR940405-1-00039 1 1341
occupational FR940405-1-00039 2 1344 1359
health FR940405-1-00039 1 1345
physicians FR940405-1-00039 1 1346
visited FR940405-1-00039 1 1348
lower FR940405-1-00039 1 1352
intoxicationtype FR940405-1-00039 1 1356
chronic FR940405-1-00039 1 1363
hypersensitivity FR940405-1-00039 1 1364
pneumonitis FR940405-1-00039 1 1365
the FR940405-1-00040 17 0 23 55 78 92 100 122 167 195 200 265 371 374 401 418 423 428
central FR940405-1-00040 1 1
nervous FR940405-1-00040 1 2
system FR940405-1-00040 2 3 389
effects FR940405-1-00040 2 4 462
reported FR940405-1-00040 1 5
by FR940405-1-00040 5 6 230 244 304 380
many FR940405-1-00040 2 7 90
do FR940405-1-00040 1 8
not FR940405-1-00040 5 9 42 83 144 368
lend FR940405-1-00040 1 10
themselves FR940405-1-00040 1 11
to FR940405-1-00040 13 12 132 154 164 172 272 306 332 339 417 422 443 483
ready FR940405-1-00040 1 13
diagnosis FR940405-1-00040 1 14
[ FR940405-1-00040 6 15 49 60 105 290 471
ex FR940405-1-00040 4 16 50 61 472
. FR940405-1-00040 22 17 20 51 54 62 99 137 151 182 209 236 292 297 321 363 376 391 410 449 473 476 490
4282 FR940405-1-00040 2 18 52
] FR940405-1-00040 6 19 53 64 114 296 475
some FR940405-1-00040 3 21 188 298
of FR940405-1-00040 16 22 91 102 124 166 175 189 192 194 222 270 299 312 393 400 436
lesser FR940405-1-00040 1 24
affected FR940405-1-00040 2 25 202
individuals FR940405-1-00040 2 26 203
either FR940405-1-00040 2 27 453
saw FR940405-1-00040 2 28 34
no FR940405-1-00040 1 29
physician FR940405-1-00040 1 30
at FR940405-1-00040 3 31 159 485
all FR940405-1-00040 2 32 186
or FR940405-1-00040 13 33 38 46 108 179 187 274 288 310 319 366 434 455
a FR940405-1-00040 8 35 70 85 145 156 173 190 340
family FR940405-1-00040 1 36
doctor FR940405-1-00040 1 37
allergist FR940405-1-00040 1 39
who FR940405-1-00040 1 40
was FR940405-1-00040 1 41
familiar FR940405-1-00040 1 43
with FR940405-1-00040 3 44 67 148
occupational FR940405-1-00040 1 45
environmental FR940405-1-00040 1 47
health FR940405-1-00040 2 48 461
air FR940405-1-00040 4 56 356 413 446
force FR940405-1-00040 1 57
procedural FR940405-1-00040 1 58
guide FR940405-1-00040 1 59
4199 FR940405-1-00040 1 63
on FR940405-1-00040 1 65
dealing FR940405-1-00040 1 66
sbs FR940405-1-00040 4 68 93 142 333
takes FR940405-1-00040 1 69
practical FR940405-1-00040 1 71
view FR940405-1-00040 1 72
: FR940405-1-00040 1 73
`` FR940405-1-00040 1 74
***in FR940405-1-00040 1 75
most FR940405-1-00040 2 76 478
cases FR940405-1-00040 3 77 406 479
sick FR940405-1-00040 1 79
building FR940405-1-00040 2 80 375
syndrome FR940405-1-00040 1 81
does FR940405-1-00040 1 82
have FR940405-1-00040 5 84 204 438 459 487
clearly FR940405-1-00040 1 86
understood FR940405-1-00040 1 87
etiology FR940405-1-00040 2 88 224
and FR940405-1-00040 12 89 95 127 199 233 264 267 328 360 387 398 425
studies FR940405-1-00040 1 94
investigations FR940405-1-00040 1 96
were FR940405-1-00040 1 97
inconclusive FR940405-1-00040 1 98
significance FR940405-1-00040 1 101
exposure FR940405-1-00040 3 103 271 305
that FR940405-1-00040 3 104 431 463
what FR940405-1-00040 1 106
chemical FR940405-1-00040 4 107 169 176 273
physical FR940405-1-00040 3 109 178 231
agent FR940405-1-00040 1 110
concentrations FR940405-1-00040 1 111
cause FR940405-1-00040 1 112
symptoms FR940405-1-00040 4 113 206 266 364
can FR940405-1-00040 3 115 226 466
be FR940405-1-00040 5 116 155 228 467 484
pathogenic FR940405-1-00040 1 117
remains FR940405-1-00040 1 118
unanswered FR940405-1-00040 1 119
, FR940405-1-00040 30 120 141 158 171 177 198 247 250 253 256 259 263 281 283 285 287 294 314 316 318 329 335 344 355 359 383 403 452 458 480
but FR940405-1-00040 1 121
realities FR940405-1-00040 1 123
worker FR940405-1-00040 1 125
complaints FR940405-1-00040 2 126 334
discomfort FR940405-1-00040 1 128
are FR940405-1-00040 4 129 302 324 336
valid FR940405-1-00040 1 130
reasons FR940405-1-00040 1 131
seriously FR940405-1-00040 1 133
address FR940405-1-00040 1 134
this FR940405-1-00040 1 135
problem FR940405-1-00040 1 136
'' FR940405-1-00040 1 138
in FR940405-1-00040 9 139 161 330 352 405 420 427 456 477
summary FR940405-1-00040 1 140
is FR940405-1-00040 2 143 378
welldefined FR940405-1-00040 2 146 149
disease FR940405-1-00040 2 147 262
causes FR940405-1-00040 1 150
it FR940405-1-00040 1 152
appears FR940405-1-00040 1 153
reaction FR940405-1-00040 1 157
least FR940405-1-00040 1 160
part FR940405-1-00040 1 162
due FR940405-1-00040 1 163
stimulation FR940405-1-00040 1 165
common FR940405-1-00040 1 168
sense FR940405-1-00040 1 170
variety FR940405-1-00040 1 174
biological FR940405-1-00040 1 180
stimuli FR940405-1-00040 1 181
its FR940405-1-00040 1 183
victims FR940405-1-00040 1 184
display FR940405-1-00040 1 185
pattern FR940405-1-00040 1 191
irritation FR940405-1-00040 2 193 241
mucous FR940405-1-00040 1 196
membranes FR940405-1-00040 1 197
worst FR940405-1-00040 1 201
neurological FR940405-1-00040 1 205
as FR940405-1-00040 5 207 278 346 385 441
well FR940405-1-00040 1 208
b. FR940405-1-00040 1 210
buildingrelated FR940405-1-00040 3 211 213 394
illness FR940405-1-00040 2 212 214
( FR940405-1-00040 1 215
bri FR940405-1-00040 1 216
) FR940405-1-00040 1 217
describes FR940405-1-00040 1 218
specific FR940405-1-00040 4 219 341 432 488
medical FR940405-1-00040 1 220
conditions FR940405-1-00040 2 221 301
known FR940405-1-00040 2 223 245
which FR940405-1-00040 1 225
often FR940405-1-00040 3 227 325 337
documented FR940405-1-00040 1 229
signs FR940405-1-00040 2 232 268
laboratory FR940405-1-00040 1 234
findings FR940405-1-00040 1 235
such FR940405-1-00040 4 237 277 345 384
illnesses FR940405-1-00040 3 238 323 395
include FR940405-1-00040 1 239
sensory FR940405-1-00040 1 240
when FR940405-1-00040 2 242 370
caused FR940405-1-00040 2 243 303
agents FR940405-1-00040 1 246
respiratory FR940405-1-00040 1 248
allergies FR940405-1-00040 1 249
nosocomial FR940405-1-00040 1 251
infections FR940405-1-00040 1 252
humidifier FR940405-1-00040 1 254
fever FR940405-1-00040 1 255
hypersensitivity FR940405-1-00040 2 257 408
pneumonitis FR940405-1-00040 1 258
legionnaires FR940405-1-00040 1 260
' FR940405-1-00040 1 261
characteristic FR940405-1-00040 1 269
biologic FR940405-1-00040 1 275
substances FR940405-1-00040 4 276 433 437 451
carbon FR940405-1-00040 1 279
monoxide FR940405-1-00040 1 280
formaldehyde FR940405-1-00040 1 282
pesticides FR940405-1-00040 1 284
endotoxins FR940405-1-00040 1 286
mycotoxins FR940405-1-00040 1 289
exs FR940405-1-00040 1 291
361 FR940405-1-00040 1 293
4144 FR940405-1-00040 1 295
these FR940405-1-00040 3 300 322 450
bioaerosols FR940405-1-00040 1 307
containing FR940405-1-00040 1 308
whole FR940405-1-00040 1 309
parts FR940405-1-00040 1 311
viruses FR940405-1-00040 1 313
fungi FR940405-1-00040 1 315
bacteria FR940405-1-00040 1 317
protozoans FR940405-1-00040 1 320
potentially FR940405-1-00040 1 326
severe FR940405-1-00040 1 327
contrast FR940405-1-00040 1 331
traceable FR940405-1-00040 1 338
contaminant FR940405-1-00040 1 342
source FR940405-1-00040 2 343 402
mold FR940405-1-00040 1 347
infestation FR940405-1-00040 1 348
and/or FR940405-1-00040 1 349
microbial FR940405-1-00040 1 350
growth FR940405-1-00040 1 351
cooling FR940405-1-00040 1 353
towers FR940405-1-00040 1 354
handling FR940405-1-00040 1 357
systems FR940405-1-00040 1 358
waterdamaged FR940405-1-00040 1 361
furnishings FR940405-1-00040 1 362
may FR940405-1-00040 2 365 367
disappear FR940405-1-00040 1 369
employee FR940405-1-00040 1 372
leaves FR940405-1-00040 1 373
susceptibility FR940405-1-00040 2 377 489
influenced FR940405-1-00040 1 379
host FR940405-1-00040 1 381
factors FR940405-1-00040 1 382
age FR940405-1-00040 1 386
immune FR940405-1-00040 1 388
status FR940405-1-00040 1 390
mitigation FR940405-1-00040 1 392
requires FR940405-1-00040 1 396
identification FR940405-1-00040 1 397
removal FR940405-1-00040 1 399
especially FR940405-1-00040 1 404
involving FR940405-1-00040 1 407
responses FR940405-1-00040 1 409
1. FR940405-1-00040 1 411
indoor FR940405-1-00040 2 412 445
contaminants FR940405-1-00040 1 414
comments FR940405-1-00040 1 415
submitted FR940405-1-00040 1 416
docket FR940405-1-00040 1 419
response FR940405-1-00040 1 421
rfi FR940405-1-00040 1 424
contained FR940405-1-00040 1 426
literature FR940405-1-00040 1 429
indicate FR940405-1-00040 1 430
classes FR940405-1-00040 1 435
been FR940405-1-00040 1 439
implicated FR940405-1-00040 1 440
contributing FR940405-1-00040 1 442
poor FR940405-1-00040 1 444
quality FR940405-1-00040 1 447
problems FR940405-1-00040 1 448
alone FR940405-1-00040 1 454
synergy FR940405-1-00040 1 457
produced FR940405-1-00040 1 460
osha FR940405-1-00040 1 464
believes FR940405-1-00040 1 465
considered FR940405-1-00040 1 468
material FR940405-1-00040 1 469
impairment FR940405-1-00040 1 470
4124 FR940405-1-00040 1 474
people FR940405-1-00040 1 481
likely FR940405-1-00040 1 482
risk FR940405-1-00040 1 486
but FR940405-1-00041 2 0 64
such FR940405-1-00041 6 1 331 496 531 618 972
susceptibility FR940405-1-00041 1 2
is FR940405-1-00041 6 3 44 85 913 1066 1082
common FR940405-1-00041 4 4 38 914 1072
and FR940405-1-00041 32 5 35 57 76 110 263 272 290 299 310 326 350 476 513 516 534 565 603 637 683 728 746 749 763 805 876 894 924 944 987 1015 1018
adverse FR940405-1-00041 1 6
effects FR940405-1-00041 15 7 16 121 282 323 330 366 392 575 587 610 647 662 687 742
can FR940405-1-00041 4 8 17 377 889
arise FR940405-1-00041 1 9
suddenly FR940405-1-00041 1 10
following FR940405-1-00041 1 11
exposure FR940405-1-00041 10 12 355 370 507 522 614 654 691 753 811
. FR940405-1-00041 69 13 37 80 83 98 128 138 168 185 201 217 241 248 268 276 279 315 320 353 384 389 413 425 440 455 464 472 480 489 523 542 545 570 573 585 608 624 633 641 644 660 685 697 705 718 732 739 758 767 772 789 816 833 849 861 868 880 883 896 929 932 946 978 997 1034 1037 1051 1058 1078
the FR940405-1-00041 25 14 52 61 67 70 74 88 102 116 119 129 280 288 321 402 560 606 677 773 795 1001 1060 1079 1085 1091
relevant FR940405-1-00041 2 15 740
be FR940405-1-00041 3 18 551 1069
categorized FR940405-1-00041 1 19
into FR940405-1-00041 2 20 994
six FR940405-1-00041 1 21
categories FR940405-1-00041 1 22
: FR940405-1-00041 1 23
irritation FR940405-1-00041 6 24 42 97 281 286 294
, FR940405-1-00041 157 25 27 29 32 34 54 56 72 104 107 109 114 140 142 144 146 148 150 152 154 156 159 170 172 174 176 178 181 187 189 191 193 196 203 205 207 209 212 219 221 223 225 227 229 231 233 236 244 250 252 255 261 271 293 297 301 305 307 309 317 335 337 341 343 346 348 367 386 395 404 408 415 417 420 427 429 431 433 436 442 444 446 448 451 457 460 467 475 482 484 486 495 499 530 536 592 594 596 602 626 629 636 665 668 670 674 679 682 700 707 709 711 714 720 722 724 727 734 736 760 769 792 797 800 802 804 818 820 822 824 826 829 835 837 839 841 844 851 853 856 864 870 872 875 918 939 943 959 971 982 986 1007 1022 1053 1055 1062 1073
pulmonary FR940405-1-00041 8 26 322 344 374 493 556 974 983
cardiovascular FR940405-1-00041 3 28 574 600
nervous FR940405-1-00041 2 30 645
system FR940405-1-00041 4 31 63 646 1003
reproductive FR940405-1-00041 2 33 741
cancer FR940405-1-00041 3 36 776 793
chemical FR940405-1-00041 3 39 528 564
sense FR940405-1-00041 1 40
or FR940405-1-00041 3 41 941 976
perception FR940405-1-00041 1 43
mediated FR940405-1-00041 1 45
through FR940405-1-00041 2 46 87
receptors FR940405-1-00041 2 47 92
found FR940405-1-00041 1 48
not FR940405-1-00041 1 49
only FR940405-1-00041 1 50
throughout FR940405-1-00041 1 51
nasal FR940405-1-00041 1 53
pharyngeal FR940405-1-00041 1 55
laryngeal FR940405-1-00041 1 58
areas FR940405-1-00041 1 59
of FR940405-1-00041 18 60 69 90 132 287 295 359 521 555 598 775 794 899 949 1039 1045 1076 1084
respiratory FR940405-1-00041 2 62 328
also FR940405-1-00041 5 65 550 577 649 778
on FR940405-1-00041 1 66
surface FR940405-1-00041 1 68
eyes FR940405-1-00041 1 71
specifically FR940405-1-00041 1 73
conjunctiva FR940405-1-00041 1 75
cornea FR940405-1-00041 1 77
[ FR940405-1-00041 39 78 136 166 183 199 215 239 246 266 274 313 382 411 423 438 453 462 470 478 540 568 622 631 639 695 703 716 730 756 765 814 831 847 859 866 878 927 1032 1049
ex FR940405-1-00041 16 79 240 267 275 314 463 471 541 569 632 640 696 860 879 928 1033
4239 FR940405-1-00041 1 81
] FR940405-1-00041 39 82 158 180 195 211 235 243 254 270 278 319 388 419 435 450 459 466 474 488 544 572 628 635 643 699 713 726 738 762 771 828 843 855 863 874 882 931 1036 1057
it FR940405-1-00041 1 84
partially FR940405-1-00041 1 86
stimulation FR940405-1-00041 1 89
these FR940405-1-00041 9 91 390 509 546 586 609 661 686 1040
that FR940405-1-00041 7 93 376 907 921 964 992 999
exposed FR940405-1-00041 1 94
persons FR940405-1-00041 1 95
perceive FR940405-1-00041 1 96
many FR940405-1-00041 2 99 399
comments FR940405-1-00041 2 100 400
to FR940405-1-00041 17 101 123 356 401 505 508 559 605 615 653 655 692 754 781 812 969 1068
docket FR940405-1-00041 2 103 403
from FR940405-1-00041 1 105
citizens FR940405-1-00041 1 106
researchers FR940405-1-00041 1 108
indoor FR940405-1-00041 9 111 125 510 582 657 786 897 916 947
air FR940405-1-00041 8 112 126 130 360 511 583 658 787
consultants FR940405-1-00041 1 113
raised FR940405-1-00041 1 115
issue FR940405-1-00041 1 117
about FR940405-1-00041 1 118
irritating FR940405-1-00041 1 120
related FR940405-1-00041 1 122
known FR940405-1-00041 1 124
contaminants FR940405-1-00041 7 127 131 361 407 512 529 567
concern FR940405-1-00041 1 133
include FR940405-1-00041 6 134 324 663 743 937 1004
formaldehyde FR940405-1-00041 4 135 437 715 755
exs FR940405-1-00041 23 137 167 184 200 216 247 383 412 424 439 454 479 623 704 717 731 757 766 815 832 848 867 1050
314 FR940405-1-00041 7 139 186 316 385 426 698 819
332 FR940405-1-00041 10 141 169 242 249 441 465 481 706 719 733
338 FR940405-1-00041 9 143 414 443 483 625 708 721 821 836
3188 FR940405-1-00041 4 145 445 823 838
3440a FR940405-1-00041 8 147 416 430 447 485 627 825 840
3446 FR940405-1-00041 11 149 171 251 277 432 710 723 735 759 768 869
3575 FR940405-1-00041 1 151
4125 FR940405-1-00041 1 153
4144 FR940405-1-00041 2 155 208
4214 FR940405-1-00041 3 157 210 1056
volatile FR940405-1-00041 1 160
organic FR940405-1-00041 1 161
compounds FR940405-1-00041 1 162
( FR940405-1-00041 5 163 259 905 1013 1028
vocs FR940405-1-00041 7 164 461 535 630 729 764 865
) FR940405-1-00041 5 165 265 912 1017 1031
3500 FR940405-1-00041 17 173 253 418 434 487 634 642 712 725 737 761 770 827 842 862 871 881
4145 FR940405-1-00041 1 175
4243 FR940405-1-00041 1 177
4320 FR940405-1-00041 1 179
ozone FR940405-1-00041 3 182 452 533
442 FR940405-1-00041 2 188 456
4134 FR940405-1-00041 1 190
4236 FR940405-1-00041 1 192
4237 FR940405-1-00041 2 194 458
carpetassociated FR940405-1-00041 1 197
chemicals FR940405-1-00041 1 198
325 FR940405-1-00041 1 202
3444d FR940405-1-00041 2 204 230
3576 FR940405-1-00041 1 206
vehicle FR940405-1-00041 1 213
exhausts FR940405-1-00041 2 214 846
36 FR940405-1-00041 2 218 817
363 FR940405-1-00041 2 220 473
3206 FR940405-1-00041 2 222 852
3238 FR940405-1-00041 1 224
3360 FR940405-1-00041 1 226
3437 FR940405-1-00041 1 228
3631 FR940405-1-00041 1 232
3659 FR940405-1-00041 1 234
combustion FR940405-1-00041 4 237 421 616 857
gases FR940405-1-00041 4 238 422 617 858
particulates FR940405-1-00041 4 245 477 638 877
manmade FR940405-1-00041 1 256
mineral FR940405-1-00041 1 257
fibers FR940405-1-00041 1 258
fiberglass FR940405-1-00041 1 260
glasswool FR940405-1-00041 1 262
rockwool FR940405-1-00041 1 264
433 FR940405-1-00041 8 269 318 387 543 571 930 1035 1052
pesticides FR940405-1-00041 1 273
present FR940405-1-00041 1 283
as FR940405-1-00041 10 284 332 396 497 532 590 619 973 1008 1023
sensory FR940405-1-00041 1 285
skin FR940405-1-00041 1 289
upper FR940405-1-00041 2 291 325
airways FR940405-1-00041 1 292
eye FR940405-1-00041 1 296
nose FR940405-1-00041 1 298
throat FR940405-1-00041 1 300
dry FR940405-1-00041 1 302
mucous FR940405-1-00041 1 303
membranes FR940405-1-00041 1 304
erythema FR940405-1-00041 1 306
headache FR940405-1-00041 3 308 591 664
abnormal FR940405-1-00041 1 311
taste FR940405-1-00041 1 312
lower FR940405-1-00041 1 327
tract FR940405-1-00041 2 329 984
rapid FR940405-1-00041 1 333
breathing FR940405-1-00041 1 334
fatigue FR940405-1-00041 3 336 593 669
increased FR940405-1-00041 2 338 553
infection FR940405-1-00041 2 339 970
rate FR940405-1-00041 1 340
bronchoconstriction FR940405-1-00041 1 342
edema FR940405-1-00041 1 345
asthma FR940405-1-00041 4 347 498 539 1014
allergies FR940405-1-00041 1 349
flulike FR940405-1-00041 1 351
symptoms FR940405-1-00041 1 352
acute FR940405-1-00041 2 354 506
low FR940405-1-00041 2 357 519
level FR940405-1-00041 1 358
results FR940405-1-00041 1 362
in FR940405-1-00041 14 363 373 379 398 537 676 790 891 915 934 1010 1025 1059 1090
primarily FR940405-1-00041 1 364
reversible FR940405-1-00041 1 365
while FR940405-1-00041 1 368
chronic FR940405-1-00041 1 369
may FR940405-1-00041 3 371 525 549
result FR940405-1-00041 3 372 378 890
fibrosis FR940405-1-00041 1 375
irreversible FR940405-1-00041 1 380
damage FR940405-1-00041 2 381 604
health FR940405-1-00041 1 391
were FR940405-1-00041 1 393
associated FR940405-1-00041 7 394 579 612 689 751 783 809
reported FR940405-1-00041 1 397
with FR940405-1-00041 10 405 491 580 613 672 690 752 784 810 961
specific FR940405-1-00041 1 406
including FR940405-1-00041 2 409 798
asbestos FR940405-1-00041 2 410 813
334 FR940405-1-00041 1 428
4124 FR940405-1-00041 1 449
vehicular FR940405-1-00041 2 468 845
exhaust FR940405-1-00041 1 469
individuals FR940405-1-00041 3 490 548 958
underlying FR940405-1-00041 1 492
disease FR940405-1-00041 8 494 601 900 950 975 981 1021 1065
are FR940405-1-00041 7 500 588 611 688 750 922 990
more FR940405-1-00041 2 501 967
susceptible FR940405-1-00041 2 502 968
than FR940405-1-00041 1 503
others FR940405-1-00041 1 504
experience FR940405-1-00041 1 514
coughing FR940405-1-00041 1 515
wheezing FR940405-1-00041 1 517
at FR940405-1-00041 2 518 552
levels FR940405-1-00041 1 520
synergism FR940405-1-00041 1 524
occur FR940405-1-00041 1 526
between FR940405-1-00041 2 527 563
aggravating FR940405-1-00041 1 538
affected FR940405-1-00041 1 547
risk FR940405-1-00041 1 554
infections FR940405-1-00041 2 557 985
due FR940405-1-00041 2 558 652
synergistic FR940405-1-00041 1 561
effect FR940405-1-00041 1 562
microbial FR940405-1-00041 2 566 885
have FR940405-1-00041 3 576 648 807
been FR940405-1-00041 4 578 650 779 808
poor FR940405-1-00041 3 581 656 785
quality FR940405-1-00041 3 584 659 788
presented FR940405-1-00041 1 589
dizziness FR940405-1-00041 1 595
aggravation FR940405-1-00041 1 597
existing FR940405-1-00041 2 599 962
heart FR940405-1-00041 1 607
carbon FR940405-1-00041 3 620 693 701
monoxide FR940405-1-00041 2 621 702
produced FR940405-1-00041 1 651
blurred FR940405-1-00041 1 666
vision FR940405-1-00041 1 667
malaise FR940405-1-00041 1 671
nausea FR940405-1-00041 1 673
ringing FR940405-1-00041 1 675
ears FR940405-1-00041 1 678
impaired FR940405-1-00041 1 680
judgement FR940405-1-00041 1 681
polyneuritis FR940405-1-00041 1 684
dioxide FR940405-1-00041 1 694
menstrual FR940405-1-00041 1 744
irregularities FR940405-1-00041 1 745
birth FR940405-1-00041 1 747
defects FR940405-1-00041 1 748
occurrence FR940405-1-00041 1 774
has FR940405-1-00041 1 777
attributed FR940405-1-00041 1 780
exposures FR940405-1-00041 1 782
particular FR940405-1-00041 1 791
lung FR940405-1-00041 2 796 1020
mesothelioma FR940405-1-00041 1 799
esophagus FR940405-1-00041 1 801
stomach FR940405-1-00041 1 803
colon FR940405-1-00041 1 806
radon FR940405-1-00041 1 830
335 FR940405-1-00041 1 834
384 FR940405-1-00041 1 850
3360h FR940405-1-00041 1 854
4294 FR940405-1-00041 1 873
2. FR940405-1-00041 1 884
contamination FR940405-1-00041 1 886
buildingrelated FR940405-1-00041 1 887
illnesses FR940405-1-00041 1 888
serious FR940405-1-00041 2 892 1074
illness FR940405-1-00041 2 893 1046
death FR940405-1-00041 1 895
transmission FR940405-1-00041 2 898 948
caused FR940405-1-00041 2 901 951
by FR940405-1-00041 2 902 952
obligate FR940405-1-00041 1 903
pathogens FR940405-1-00041 1 904
microbes FR940405-1-00041 1 906
require FR940405-1-00041 1 908
a FR940405-1-00041 2 909 1070
living FR940405-1-00041 1 910
host FR940405-1-00041 1 911
environments FR940405-1-00041 1 917
especially FR940405-1-00041 1 919
those FR940405-1-00041 2 920 960
overcrowded FR940405-1-00041 1 923
inadequately FR940405-1-00041 1 925
ventilated FR940405-1-00041 1 926
diseases FR940405-1-00041 4 933 991 998 1041
this FR940405-1-00041 2 935 995
category FR940405-1-00041 2 936 996
influenza FR940405-1-00041 1 938
rhinovirus FR940405-1-00041 1 940
colds FR940405-1-00041 1 942
measles FR940405-1-00041 1 945
opportunistic FR940405-1-00041 1 953
microorganisms FR940405-1-00041 1 954
usually FR940405-1-00041 1 955
affects FR940405-1-00041 1 956
compromised FR940405-1-00041 1 957
conditions FR940405-1-00041 1 963
make FR940405-1-00041 1 965
them FR940405-1-00041 1 966
immunodeficiency FR940405-1-00041 1 977
legionnaires FR940405-1-00041 2 979 1063
' FR940405-1-00041 2 980 1064
humidifier FR940405-1-00041 1 988
fever FR940405-1-00041 1 989
fall FR940405-1-00041 1 993
affect FR940405-1-00041 1 1000
immune FR940405-1-00041 1 1002
allergic FR940405-1-00041 1 1005
reactions FR940405-1-00041 2 1006 1027
seen FR940405-1-00041 2 1009 1024
antibodymediated FR940405-1-00041 1 1011
responses FR940405-1-00041 1 1012
rhinitis FR940405-1-00041 1 1016
interstitial FR940405-1-00041 1 1019
cellmediated FR940405-1-00041 1 1026
hypersensitivity FR940405-1-00041 1 1029
pneumonitis FR940405-1-00041 1 1030
all FR940405-1-00041 1 1038
produce FR940405-1-00041 1 1042
substantial FR940405-1-00041 1 1043
amounts FR940405-1-00041 1 1044
each FR940405-1-00041 1 1047
year FR940405-1-00041 1 1048
441 FR940405-1-00041 1 1054
us FR940405-1-00041 2 1061 1092
considered FR940405-1-00041 1 1067
fairly FR940405-1-00041 1 1071
form FR940405-1-00041 1 1075
pneumonia FR940405-1-00041 1 1077
legionella FR940405-1-00041 1 1080
bacterium FR940405-1-00041 1 1081
one FR940405-1-00041 1 1083
top FR940405-1-00041 1 1086
three FR940405-1-00041 1 1087
bacterial FR940405-1-00041 1 1088
agents FR940405-1-00041 1 1089
which FR940405-1-00041 1 1093
causes FR940405-1-00041 1 1094
